EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

Driel, P.B.A.A. van; Boonstra, M.C.; Slooter, M.D.; Heukers, R.; Stammes, M.A.; Snoeks, T.J.A.; ... ; Oliveira, S. (2016)

Article / Letter to editor

• Photodynamic therapy
• Tumor targeting
• Nanobody or VHH
• Quantitative fluorescence spectroscopy
• EGFR
• Head and neck cancer

• All authors: Driel, P.B.A.A. van; Boonstra, M.C.; Slooter, M.D.; Heukers, R.; Stammes, M.A.; Snoeks, T.J.A.; Bruijn, H.S. de; Diest, P.J. van; Vahrmeijer, A.L.; Henegouwen, P.M.P.V.E.; Velde, C.J.H. van de; Lowik, C.G.M.; Robinson, D.J.; Oliveira, S.
• Date: 2016-05-10
• Journal: Journal of Controlled Release
• Volume: 229
• Pages: 93 - 105
• DOI: doi:10.1016/j.jconrel.2016.03.014